News
News
Pharma Pulse
Multimedia
Editorial Podcasts
Editorial Videos
Profiles in Medicine
Conferences
Conference Coverage
Conference Listing
Publications
Pharmaceutical Executive
Brand Insights
Resources
E-Books
Events
Sponsored Podcasts
Sponsored Videos
Webcasts
Whitepapers
Subscribe
Spotlight
Pharmaceutical Executive APEX Awards
Latest Executive Roundtables
Topic
DE&I
Executive Profiles
Sales and Marketing
Strategy
Technology
News
News
Pharma Pulse
Multimedia
Editorial Podcasts
Editorial Videos
Profiles in Medicine
Conferences
Conference Coverage
Conference Listing
Publications
Pharmaceutical Executive
Brand Insights
Resources
E-Books
Events
Sponsored Podcasts
Sponsored Videos
Webcasts
Whitepapers
Subscribe
Advertisement
Sales & Marketing
| DE&I
| Executive Profiles
| Executive Roundtable
| Finance
| Global
| Industry Trends
| Leadership
| Legal
| Market Access
| Opinion
| Pandemic
| Patient Engagement
| Pricing
| R&D/Clinical Trials
| Regulatory
| Strategy
| Supply Chain
| Sustainability
| Technology
View All >>
DE&I
Executive Profiles
Executive Roundtable
Finance
Global
Industry Trends
Leadership
Legal
Market Access
Opinion
Pandemic
Patient Engagement
Pricing
R&D/Clinical Trials
Regulatory
Sales & Marketing
Strategy
Supply Chain
Sustainability
Technology
SPOTLIGHT
-
Pharmaceutical Executive APEX Awards
| Latest Executive Roundtables
Margaret Grubb
home
/
authors
/
margaret-grubb
Margaret Grubb is a former pharmaceutical representative with a master's in education.
Articles
New content coming soon.
Latest Updated Articles
Published: June 19th 2024
| Updated: June 24th 2024
Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Published: December 9th 2024
| Updated: December 11th 2024
Yescarta Demonstrates Promise in Treating Relapsed/Refractory Large B-Cell Lymphoma
Published: December 9th 2024
| Updated: December 11th 2024
Pharma Pulse 12/9/24: Technology's Role in Achieving Greater DE&I, Out-of-Pocket MS Med Costs Rise, Others Drop & more
Published: December 6th 2024
| Updated: December 11th 2024
The Launch of SPIMA Therapeutics
Published: November 20th 2024
| Updated: December 11th 2024
The Influence of PD-1 Inhibitor Label Restrictions on Future Studies
Published: November 5th 2024
| Updated: December 11th 2024
FDA Challenges to Broad Label Laws for PD-1 Inhibitors